XLVets, the collaborative group of independent veterinary practices, is inviting independent vets to come to one of three national meetings it is holding at Chesford Grange in Kenilworth to explain the benefits of joining the group.

The small animal and business meeting takes place on the 2^nd and 3^rd October. The farm and business national meeting is on the 18^th and 19^th September, and the equine and business meeting is on the 9^th and 10^th October.

The small animal meeting will also cover other topics such as the art of conversations to dentistry, while the farm meeting will focus on team working, competitive advantage, genomics and mental resilience.

All three events include a team-based activity and a social evening which offers the chance to network and exchange experiences and ideas.

Susan Goodfellow, the Chief Marketing Officer at XLVets said: "It's fine to know what we do but to actually experience it as part of our community is quite different. We know that talking to members and being part of a group of individuals that come together to determine their own future is the best way for veterinary professionals to see what's possible and how we strive for excellence together."

XLVets is also encouraging anyone who is thinking about starting their own practice to attend the events; the company has a number of programmes designed to support prospective owners with things like finding funding, identifying the right financial set up, and acquiring the skills needed to lead a team effectively.

Susan says many vets have a strong entrepreneurial mindset but lack support or know-how to allow them to take the first step to ownership: "Locum roles and mobile set ups are often stepping stones to practice ownership but the barriers can seem significant, not to mention any personal reservations people might have about all it entails. Support from like-minded colleagues who can openly share their experiences can help to make it seem possible, desirable and achievable."

Veterinary professionals wishing to attend one of the meetings should contact Colm McGinn, Chief of Implementation, in confidence, at colm.mcginn@xlvets.co.uk or call 01228 711788.

Dechra Veterinary Products has launched Tranquinervin, an injectable acepromazine for horses.

Tranquinervin, which contains 10 mg/ml acepromazine, is indicated for anaesthetic premedication, tranquilisation and sedation.

Emma Jennings, Brand Manager at Dechra said: "Tranquinervin provides tranquillisation or a mild sedation for several hours, making it a valuable tool for many day-to-day veterinary scenarios.

"At low doses, acepromazine reduces anxiety which is beneficial for use in horses prior to shoeing or transportation. At higher dose rates, it is an effective sedative for use in situations like dentistry or handling. The relaxant effects also aid examination of the penis in horses and the treatment of tetanus and choke.

"There is also reduced anaesthetic risk reported following sole premedication with acepromazine in healthy horses¹."

Tranquinervin is available in a 20 ml vial with a 56 day broached shelf life. It can be used in conjunction with Dechra’s equine anaesthesia and analgesia app which is designed to help you choose optimal anaesthetic protocols and calculate anaesthetic drug doses and administration rates quickly and easily. 

For more information, go to: www.dechra.co.uk/products/equine

Reference

1. Johnston, J.M; Eastment, J.K; Wood, J.L.N. et. al (2002) ‘The confidential enquiry into perioperative equine fatalities (CEPEF): mortality results of phase 1 and 2.’ Vet. Anaesthesia and Analgesia 29, pp.159-17

York-based Dr Michael Richard Jones has been suspended by the RCVS Disciplinary Committee for two months, for making dishonest entries in horse passports and subsequently making dishonest entries in the same horses’ clinical records.

The Disciplinary Committee heard three charges against Dr Jones.

The first and second charges were that, in March 2018, Dr Jones made signed entries in the passports and made corresponding entries in clinical records of four horses indicating that he had administered an influenza vaccination booster to each horse on 15 March 2018 and in relation to another horse a tetanus booster, when in fact he had administered the vaccination boosters on 21 March 2018, and that his conduct was misleading, dishonest and undermined the integrity of a vaccination process designed to promote animal welfare.

The third charge was that, on or around 21 March 2018, Dr Jones failed to make any entries in the clinical records for a horse in relation to an examination on 21 March 2018.

At the outset of the hearing Dr Jones admitted the facts in the first and second charges, and accepted that his actions were misleading, dishonest and that they undermined the integrity of a vaccination process. However, he disputed certain aspects of the written statements of the College’s witnesses. In particular he wanted his conduct to be taken in the context of the pressures that he was working under on that day, primarily that he was in a stressed state having had to euthanase a valuable stallion at the conclusion of his previous client appointment.

Dr Jones did not admit the third charge, explaining that he did not remember examining the horse on 21 March 2018 as alleged.

Based on Dr Jones' own admissions, the Committee found the first and second charges proven. 

Regarding the third charge, the Committee heard evidence from the horse’s owner who said they were present during the examination taking place and the Committee was satisfied that the respondent did examine the horse on 21 March 2018 and that he had a duty to make a brief clinical note on the examination. As Dr Jones admitted that he made no such note, the Committee found the charge to have been proven to the requisite standard.

Having found the charges proven, the Committee then went on to consider whether or not Dr Jones’ proven conduct amounted to serious professional misconduct. The Committee, having considered the aggravating and mitigating factors, found that Dr Jones’ conduct as found proved in relation to both charges one and two, did constitute serious professional misconduct.

However, with regards to charge three, the Committee accepted that the respondent simply forgot that he had examined the horse and, therefore, the Committee was not satisfied that the failure to compile a record entry covering the horse’s examination constituted serious professional misconduct.

The Committee then considered what sanction to impose on Dr Jones in relation to the facts found proven in charges one and two. In doing so it took into account the 78 written testimonials and 4 character witnesses called on behalf of Dr Jones.

Ian Green, who chaired the Committee and spoke on its behalf, said: "The Committee’s decision on sanction has been based on an acceptance that the respondent’s conduct on this occasion was out-of-character, as the evidence of his character witnesses and the contents of the letters submitted in his support by his clients and other veterinary colleagues assert. The Committee also accepts that the respondent self-reported himself to his employer and to the College and has made a full and frank admission of his wrongdoing.

"Consideration was given to whether the sanction of a reprimand and/or warning as to future conduct would adequately reflect the gravity of the misconduct, however, after careful reflection it was concluded that such a sanction could not be justified. The reason is that acts of falsification involve acts of dishonesty by a professional person acting in a professional capacity, and the gravity of the matter arises not simply from the dishonesty but also from the possible consequences of the false certification. It should be clearly understood by members of the veterinary profession that, in appropriate false certification cases, the sanction of removal from the Register is one which may well be imposed."

The Committee therefore decided that suspending Dr Jones from the Register for two months would be the most appropriate sanction.

Following the identification of testosterone in a vial of Bova’s long acting omeprazole injection for horses in mid-June 2019 by the New South Wales (NSW) racing authority, Bova says subsequent tests have now confirmed that the level of contamination was less than one millionth of the internationally accepted standard for impurities, well below the level that could have resulted in a positive drug test.

After the contamination was first identified, sales of the product in Australia were stopped immediately and Bova initiated an investigation.

The British Horseracing Authority then conducted its own analysis of samples of the UK product, discovering that it too was contaminated with testosterone.

However, Bova says the levels of testosterone in the end product were confirmed to be 400-700 pg/ml, which is less than one millionth of the internationally accepted standard for impurities (1 picogram being equal to one billionth of a milligram).

Nick Bova, managing Director of Bova UK, said: "We have consulted veterinary pharmacologists and sports medicine specialists who have given their opinion that these levels are within accepted standards and could neither have a clinical effect nor result in a positive blood or urine test for testosterone in competition horses.

"The levels of testosterone within the product are inconsequential compared to endogenous production in mares and geldings as well as stallions and higher levels are found frequently in feed and water sources; testosterone being a common compound produced by humans and animals from multiple organs."

The source of the contamination was traced to the excipient used in the product, which was used by Bova Aus and Bova UK. Both companies have now switched their supplier of this excipient. Bova says all testing done on the new supplier has shown no traces of testosterone, even with the new extra sensitive method of analysis which is capable of reaching picogram levels.

Nick added: "Whilst we hope to reassure you that the use of long acting injectable omeprazole will not have had adverse implications for your patients or clients we can also reassure you that we are not complacent about the presence of impurities in any of our products, particularly an impurity that is of such significance to equestrian sport.

"Although the level of impurities is well within the accepted international standard, we have changed the supplier of the excipient in question. We have established an analytical method capable of testing down to picogram levels, which has been used to test the end product to ensure there are no further concerns with future batches.

"We sincerely apologise for any inconvenience this issue may have caused. Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment and we can reassure anyone who has used the product in recent months, or has product that they are due to use, that they can do so safely.

"However, we would draw attention to the recent statement from the BHA that they do not wish the product to be used in horses in training currently."

Visit www.bova.co.uk for further information.

Austin Davis Biologics (ADB) will be launching a new blood test service for diagnosing small redworm (cyathostomin) infections in horses, in September.

The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.

ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.

Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses. 

The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."

Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."

Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service. 

Improve International, organiser of the Official Veterinarian (OV) Conference, is offering OVs the chance to win a free or discounted ticket to attend a day of this year’s conference.

To win, OVs are asked to submit a question to a speaker of their choice by Monday 12 August.

The question judged the most interesting will win the free ticket and five runners up will each receive a 50% discounted ticket. In each case, the OV can choose their preferred day to attend.

The full programme can be found at: https://officialvet.com/programme/ and questions can be submitted to enquiries@improve-ov.com or by private message through Facebook at https://www.facebook.com/officialvet/

Improve says this year's speakers will address an increasing threat from notifiable diseases in the UK, with evidence of M. bovis infection linked to a raw pet food diet identified in cats, an outbreak of equine viral arteritis in Dorset and cases of African swine fever recently reported in western Europe. The programme includes small animal and farm animal focused lecture streams on both days, an equine stream on the first day and a series of specialist workshops on the second.

Dr Andrew Soldan (pictured right), Veterinary Director at APHA, said: "Notifiable diseases are an ongoing threat to the health and welfare of animals and our farming industries in the UK. Animal keepers and vets play a vital role in their early detection. We’re particularly concerned by the risk of African swine fever following the disease being found in wild boar in Belgium last year. 

"Small animal and mixed practice OVs can help us reduce the risk of ASF infecting UK pigs by informing pig keepers of the risk and advising them of the importance of not feeding kitchen scraps and catering waste to pigs.

"We’re currently in the vector season so bluetongue is another disease to look out for in cattle and sheep. Providing advice to livestock farmers on how they can minimise the risk of its introduction through vaccination and checking the source of imported animals is another important role for OVs."

David Babington MRCVS, Business Development Director at Improve International, said: "OVs play a crucial role in monitoring our exposure to notifiable diseases and in alerting us to possible outbreaks. For this reason, providing a full update on the current disease status is an important element of this year’s programme, though we will also cover other important topics, including illegal puppy imports, pet travel and, inevitably I’m afraid, Brexit."

For more information on the Official Veterinarian Conference and exhibition or to register visit: www.officialvet.com.

RCVS Knowledge has announced the launch of a CPD roadshow covering quality improvement (QI) for equine professionals and QI in the clinical management of hip dysplasia in dogs, starting in October.

The equine events will initially take place at Rossdales Equine Hospital in Suffolk on 22^nd October and at Ashbrook Veterinary Hospital in Cheshire on 5^th December.

The roadshow will see a range of speakers renowned in the fields of equine veterinary medicine and QI share practical examples of improving outcomes for equine patients. Interactive workshops, real-life scenarios and case studies will show how QI techniques can be applied in practice to help teams prevent and respond to errors.

Confirmed speakers include Professor Debra Archer, Head of Equine Surgery and Professor in Equine Surgery at the University of Liverpool, Dr Alice Bird, Senior Clinical Anaesthetist at the Animal Health Trust and Dr Rachel Dean, Director of Clinical Research and Excellence in Practice, VetPartners.

President Elect of BEVA, Tim Mair, said: "There are many challenges to being an equine vet and running a successful equine practice. Even in large practices and equine hospitals, there is a risk that we operate in our own little bubble and assume that what we are doing is best practice, whereas in reality we could often do a better job.

"Clinical governance and quality improvement are tools that allow us to critically appraise our day-to-day work and identify ways in which we can continuously improve what we do – to the benefit of our patients and clients, as well as to ourselves."

The canine hip dysplasia roadshow will begin on 9^th October in Gatwick, Surrey.

The event will review the condition prevalent in dogs, how best to investigate it and the available treatment options. Case examples will be used to show how the evidence can be evaluated, explain how to measure treatment outcomes and show how the use of checklists can help minimise potential errors.

It will be hosted by Mark Morton, RCVS Specialist in Small Animal Surgery (Orthopaedics). He said: "As vets we probably all undertake bits of QI on a day-to-day basis (whether we realise it or not!) but there is so much more we can do to embed it into our clinical work. Checklists, treatment guidelines and clinical auditing significantly improve our patient care and our outcomes.

"Whilst looking at hip dysplasia and the treatment options in detail, hopefully this roadshow will show how we can apply these ideas to improve our management of this condition as well as using them elsewhere.”

For the full programme of each event and to buy tickets, visit bit.ly/RCVSKnowledgeEvents.

Anyone interested in booking an RCVS Knowledge roadshow for their region can do so by contacting ebvm@rcvsknowledge.org.

Rossdales Veterinary Surgeons, which remains one of the largest independent equine veterinary practices in Europe, is celebrating 60 years of service by hosting ‘Diamond Series’ equine CPD events for general practitioners and students.

Founded by Peter Rossdale in Newmarket in 1959, the practice now boasts a team of 50 veterinary surgeons and has established an international reputation for providing world class ambulatory, referral and laboratory services. The team is led by RCVS, European and American recognised veterinary specialists and operates from four sites in Newmarket, Exning, Hertfordshire and Lambourn. 

Each year, Rossdales Equine Hospital in Exning hosts a large number of CPD courses which often include internationally recognised guest speakers who lecture alongside Rossdales’ specialist clinicians, with delegates attending from as far afield as Europe, Singapore, Dubai and Australia.

To celebrate the practice’s Diamond anniversary, Rossdales is hosting a special 'Diamond Series' of CPD events in 2019 in addition to its usual programme of educational courses.

Mike Shepherd, Managing Partner at Rossdales, said: "Since the practice was established by Peter Rossdale in 1959, it has always prided itself on clinical research and the willing distribution of this and other information to the veterinary profession. This ‘Diamond Anniversary’ series of CPD events is an initiative that we hope will benefit many of our veterinary colleagues. The first of these special events, the Diamond Series Veterinary Nursing Congress, was held at the beginning of June and was fully subscribed. We’re very pleased by the excellent feedback it generated."

Two further ‘Diamond Series’ events are scheduled, for veterinary surgeons and veterinary students respectively:

The Diamond Series Veterinary Surgeons Congress takes place on Friday,12^th and Saturday, 13^th July 2019 and is for all veterinary surgeons with an interest in equine or mixed practice. The programme covers a wide area of subjects, with talks provided by 12 veterinary surgeons from Rossdales Equine Hospital and Rossdales Laboratories. It also includes admission to The Moët & Chandon July Festival at Newmarket Racecourse on Saturday, 13th July.

The Diamond Series Undergraduate Congress will take place on Saturday, 10^th and Sunday, 11^th August 2019. This course is aimed at all current veterinary undergraduates who want to gain more knowledge and experience in the fields of equine veterinary medicine and surgery. There will be talks and presentations from 9 veterinary surgeons from Rossdales Equine Practice, Rossdales Equine Hospital and Rossdales Laboratories. There will also be a course dinner on the Saturday evening.

For more information, visit www.rossdales.com/news-events.

Jurox (UK) Ltd has launched AceSedate, a UK-licensed injectable acepromazine for horses.

AceSedate for horses contains 10mg/ml acepromazine as its active ingredient, which the company says means a lower dose volume is required compared to the non-UK licensed equine acepromazine options available.

The dosage of AceSedate is 0.03-0.10 mg per kg bodyweight, however Jurox recommends that the lower end of the dose range is always selected where possible. It can be administered via intramuscular or slow intravenous injection.

AceSedate is supplied in a multidose vial and the shelf life after opening the immediate packaging is 28 days.

Richard Beckwith, country manager of Jurox (UK) Ltd, said: "The launch of AceSedate means injectable acepromazine is now licensed in the UK for horses, giving vets peace-of-mind that a licensed product is now available. It is a welcome addition to our equine anaesthesia, analgesia and sedation portfolio."

For more information, visit: www.jurox.com/uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail customerservice@jurox.co.uk.

The BVA has published a new policy statement outlining its 'hub and spoke' vision for the future of patient care, whereby veterinary surgeons are at hub of treatment, directing patients to and coordinating treatment by allied professionals.

The allied professionals that the BVA says should be led by veterinary surgeons include: Registered Veterinary Nurses (RVNs), Official Auxiliaries/ Meat Hygiene Inspectors, embryo transfer technicians, equine dental technicians, foot trimmers, farriers, hydrotherapists, animal behaviourists and veterinary physiotherapists.

To clarify where the responsibility for a patient sits and how it is shared between veterinary surgeons and allied professionals, the new policy statement also calls for: 

• The regulation of allied professionals to include mandatory veterinary diagnosis and oversight and appropriate access to veterinary records as pre-requisites before treatment;

• Clarity on the delegation of duties for RVNs under Schedule 3 of the Veterinary Surgeons Act and protection of the ‘veterinary nurse’ title in legislation;

• Consultation with the veterinary profession on any regulatory changes that may arise as a result of technological or other innovation.

British Veterinary Association President Simon Doherty (pictured right) said: "Against an evolving landscape, it’s essential that the veterinary profession keeps pace with change and addresses the challenges and opportunities it presents.

"Vets across sectors have always worked closely with allied professionals. The hub and spoke model acknowledges and clarifies this working relationship with clear lines of accountability and responsibility for the animals under our care. It also emphasises that vets’ right to diagnose, prescribe, and undertake surgical procedures and medical treatments must not be undermined.

"An effective and efficient vet-led team can help deliver better animal health and welfare, improved client care, and more effective use of skills within the veterinary professions. Given the ongoing workforce shortages, a strengthened veterinary workforce also has the potential to ease recruitment and retention concerns for both vets and RVNs and offer improved wellbeing.

"BVA will continue working with professional bodies and organisations to formalise the hub and spoke model, promote the value of regulation, and drive up professional standards."

The British Equine Veterinary Association has announced that colic will be a key topic on the scientific programme at Congress this year, which runs from 11th to 14th September at the Birmingham ICC.

Global names in gastroenterology will be sharing the latest knowledge to help veterinary surgeons and nurses support the work of the BHS and Nottingham University’s REACT to colic campaign, which is designed to help vets and horse owners work together for colic patients.

On Friday 13th September there'll be a two-hour session chaired by Harry Carslake, a diplomate of the American College of Veterinary internal medicine (ACVIM). The session will involve five experts speaking about aspects of colic, followed by discussion and the opportunity for questions from delegates.

• Natasha Jocelyn, Internal Medicine Specialist, Sussex Equine Hospital, will speak about managing the acute colic in the field: what to do when flunixin doesn’t work.

• Prof. Dr. Gunther Van Loon European Veterinary Specialist in Equine Internal Medicine, Ghent University, Belgium, will discuss managing acute colic in the equine hospital.

• Dr Nathan Slovis member of the American College of Internal Veterinary Medicine, Director of the McGee Medicine Department and a partner at Haygard Equine Medical Institute in Lexington, Ky will explain colic guidelines – can ‘algorithms’ help?

• Prof. Dr Lutz Goehring European Veterinary Specialist in Equine Internal Medicine, Ludwig-Maximilians University Munich, will explore the question ‘is there an evidence-based approach to managing enteritis?’

• David Rendle European Veterinary Specialist in Equine Internal Medicine, Rainbow Equine Hospital, North Yorkshire, will look at parasitic disease as a cause of colic and methods of management.

All BEVA Congress delegates get a certificate of attendance worth seven hours of CPD.

If you're struggling for time or torn between several lectures you can use the BEVA Congress Encore Room to play back missed lectures at your convenience. BEVA Congress is also providing day crèche for children between the ages of 0-8 years. Find out more here.

Anyone who registers for Congress before 8 May 2019 will receive significantly reduced booking fees, and BEVA members save up to £379 on their Congress passes.

A new study published in Equine Veterinary Education¹ has confirmed that if veterinary surgeons are trained to use a Ridden-Horse-Ethogram they are better able to recognise pain-related behaviour in horses, which may reflect lameness or back or sacroiliac pain.

This, say the authors, should in turn help them to communicate potential performance problems more effectively with their clients.

Conducted by Dr Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust in Newmarket, the study compared the real-time application of the Ridden-Horse-Ethogram with analysis of video recordings of the horses by a trained assessor and determined whether vets, after preliminary training, could apply the ethogram in real time in a consistent way and in agreement with an experienced assessor.

Twenty horse and rider combinations were used for the study. The horses were in regular work and were capable of working ‘on the bit’. They were assessed by a chartered physiotherapist and then a Society of Master Saddlers (SMS) qualified saddle fitter checked the fit, placement, balance and suitability of each horse’s saddle. Eleven horses were found to have ill-fitting saddles and 14 had back muscle tension or pain but these did not influence the behaviour scores.

The horses were also assessed by an independent lameness expert. Sixteen showed low-grade lameness or abnormalities of canter, which were likely to be pain induced but did not prevent the horses from being used for the study.

All 20 horses were given a 15-minute ridden warm-up before executing an 8-minute purpose-designed preliminary level dressage test. During each dressage test a team of 10 equine vets, who were selected from 40 volunteers and given preliminary training, applied the Ridden-Horse-Ethogram. They assessed each horse for the presence of a total of 24 behaviours that occur more commonly in lame horses compared with non-lame horses. It has previously been shown that the presence of ≥8 behavioural markers is likely to indicate the presence of musculoskeletal pain.

All behaviours were scored with a binary method as present or absent. The ethogram was also applied to each horse by an experienced trained assessor (Dr Dyson) and the tests were filmed so that the experienced assessor could make a comparison between her real-time behaviour assessments and video analysis.

There was good agreement between the expert’s scores and the volunteer vets’ scores and excellent consistency in overall agreement among the volunteers. The scores also reflected the volunteers’ capacity to use the ethogram to identify lameness status, with higher scores awarded to the lame horses compared with the non-lame horses.

There was no significant difference in real-time scores and video-based scores for the experienced assessor, verifying the reliability of the system.

Sue said: "The study confirms that with basic training veterinary observers can use the ridden horse ethogram with consistency as an effective tool to help identify musculoskeletal pain which could reflect lameness or back or sacroiliac pain.

"The volunteers were unanimously positive about the potential value of the ethogram in helping them to determine the presence of musculoskeletal pain in horses performing poorly or at pre-purchase examinations."

Sue and her team are now working with the evidence-based online educational resource Equitopia, in conjunction with Padma Videos, to produce a training video to enable vets, owners, riders, trainers and paraprofessionals to learn how to apply the Ridden-Horse-Ethogram.

For more information, email info@equitopiacenter.com.

1. Can veterinarians reliably apply a whole horse ridden ethogram to differentiate non lame and lame horses based on live horse assessment of behaviour?  S. Dyson, K. Thomson, L. Quiney, A. Bondi and A. D. Ellis Equine Vet. Educ. 2019, doi: 10.1111/eve.13104